ArticleGynecologic oncology2012

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.

Marta Szajnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.